205 related articles for article (PubMed ID: 24528792)
1. Mesenchymal stem cell therapy for salivary gland dysfunction and xerostomia: a systematic review of preclinical studies.
Jensen DH; Oliveri RS; Trojahn Kølle SF; Fischer-Nielsen A; Specht L; Bardow A; Buchwald C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):335-342.e1. PubMed ID: 24528792
[TBL] [Abstract][Full Text] [Related]
2. Salivary Gland Hypofunction and Xerostomia in Head and Neck Radiation Patients.
Jensen SB; Vissink A; Limesand KH; Reyland ME
J Natl Cancer Inst Monogr; 2019 Aug; 2019(53):. PubMed ID: 31425600
[TBL] [Abstract][Full Text] [Related]
3. Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline.
Mercadante V; Jensen SB; Smith DK; Bohlke K; Bauman J; Brennan MT; Coppes RP; Jessen N; Malhotra NK; Murphy B; Rosenthal DI; Vissink A; Wu J; Saunders DP; Peterson DE
J Clin Oncol; 2021 Sep; 39(25):2825-2843. PubMed ID: 34283635
[TBL] [Abstract][Full Text] [Related]
4. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for head and neck cancer: MARSH: Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction.
Blitzer GC; Rogus-Pulia NM; Mattison RJ; Varghese T; Ganz O; Chappell R; Galipeau J; McDowell KA; Meyers RO; Glazer TA; Kimple RJ
Cytotherapy; 2022 May; 24(5):534-543. PubMed ID: 35183442
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life.
Jensen SB; Pedersen AM; Vissink A; Andersen E; Brown CG; Davies AN; Dutilh J; Fulton JS; Jankovic L; Lopes NN; Mello AL; Muniz LV; Murdoch-Kinch CA; Nair RG; Napeñas JJ; Nogueira-Rodrigues A; Saunders D; Stirling B; von Bültzingslöwen I; Weikel DS; Elting LS; Spijkervet FK; Brennan MT;
Support Care Cancer; 2010 Aug; 18(8):1039-60. PubMed ID: 20237805
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy.
Sasportas LS; Hosford DN; Sodini MA; Waters DJ; Zambricki EA; Barral JK; Graves EE; Brinton TJ; Yock PG; Le QT; Sirjani D
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Jul; 116(1):e37-51. PubMed ID: 23643579
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of mesenchymal stem cell therapy in rodent models of radiation-induced xerostomia and oral mucositis: a systematic review.
Guan Z; Zhang J; Jiang N; Tian M; Wang H; Liang B
Stem Cell Res Ther; 2023 Apr; 14(1):82. PubMed ID: 37046350
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact.
Jensen SB; Pedersen AM; Vissink A; Andersen E; Brown CG; Davies AN; Dutilh J; Fulton JS; Jankovic L; Lopes NN; Mello AL; Muniz LV; Murdoch-Kinch CA; Nair RG; Napeñas JJ; Nogueira-Rodrigues A; Saunders D; Stirling B; von Bültzingslöwen I; Weikel DS; Elting LS; Spijkervet FK; Brennan MT; ; ;
Support Care Cancer; 2010 Aug; 18(8):1061-79. PubMed ID: 20333412
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal Stromal/Stem Cell Therapy Improves Salivary Flow Rate in Radiation-Induced Salivary Gland Hypofunction in Preclinical in vivo Models: A Systematic Review and Meta-Analysis.
Carlander AF; Gundestrup AK; Jansson PM; Follin B; Hoeeg C; Kousholt BS; Larsen RT; Jakobsen KK; Rimborg S; Fischer-Nielsen A; Grønhøj C; Buchwald CV; Lynggaard CD
Stem Cell Rev Rep; 2024 May; 20(4):1078-1092. PubMed ID: 38430363
[TBL] [Abstract][Full Text] [Related]
10. Functionality of bone marrow mesenchymal stromal cells derived from head and neck cancer patients - A FDA-IND enabling study regarding MSC-based treatments for radiation-induced xerostomia.
Blitzer GC; Paz C; Glassey A; Ganz OR; Giri J; Pennati A; Meyers RO; Bates AM; Nickel KP; Weiss M; Morris ZS; Mattison RJ; McDowell KA; Croxford E; Chappell RJ; Glazer TA; Rogus-Pulia NM; Galipeau J; Kimple RJ
Radiother Oncol; 2024 Mar; 192():110093. PubMed ID: 38224919
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal/stem cell therapy for radiation-induced salivary gland hypofunction in animal models: a protocol for a systematic review and meta-analysis.
Jansson PM; Lynggaard CD; Carlander AF; Jensen SB; Follin B; Hoeeg C; Kousholt BS; Larsen RT; Grønhøj C; Jakobsen KK; Rimborg S; Fischer-Nielsen A; Menon JML; von Buchwald C
Syst Rev; 2022 Apr; 11(1):72. PubMed ID: 35436971
[TBL] [Abstract][Full Text] [Related]
12. The preventive and therapeutic effect of acupuncture for radiation-induced xerostomia in patients with head and neck cancer: a systematic review.
Zhuang L; Yang Z; Zeng X; Zhua X; Chen Z; Liu L; Meng Z
Integr Cancer Ther; 2013 May; 12(3):197-205. PubMed ID: 22791311
[TBL] [Abstract][Full Text] [Related]
13. Salivary gland and associated complications in head and neck cancer therapy.
Kumar S; Ram S; Navazesh M
J Calif Dent Assoc; 2011 Sep; 39(9):639-47. PubMed ID: 22034798
[TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness and safety of acupuncture in the treatment of irradiation-induced xerostomia in patients with head and neck cancer: a systematic review.
O'Sullivan EM; Higginson IJ
Acupunct Med; 2010 Dec; 28(4):191-9. PubMed ID: 21062848
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study.
Jakobsen KK; Carlander AF; Grønhøj C; Todsen T; Melchiors J; Paaske N; Madsen AKØ; Kastrup J; Ekblond A; Haack-Sørensen M; Farhadi M; Maare C; Friborg J; Lynggard CD; von Buchwald C
Trials; 2023 Sep; 24(1):567. PubMed ID: 37658468
[TBL] [Abstract][Full Text] [Related]
16. Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): A pilot, first-in-human study of interferon gamma-stimulated marrow mesenchymal stromal cells for treatment of radiation-induced xerostomia.
Blitzer GC; Glazer T; Burr A; Gustafson S; Ganz O; Meyers R; McDowell KA; Nickel KP; Mattison RJ; Weiss M; Chappell R; Rogus-Pulia NM; Galipeau J; Kimple RJ
Cytotherapy; 2023 Nov; 25(11):1139-1144. PubMed ID: 37589639
[TBL] [Abstract][Full Text] [Related]
17. Post-radiation xerostomia therapy with allogeneic mesenchymal stromal stem cells in patients with head and neck cancer: study protocol for phase I clinical trial.
Strojan P; Plavc G; Kokalj M; Mitrovic G; Blatnik O; Lezaic L; Socan A; Bavec A; Tesic N; Hartman K; Svajger U
Radiol Oncol; 2023 Dec; 57(4):538-549. PubMed ID: 38038413
[TBL] [Abstract][Full Text] [Related]
18. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.
Grønhøj C; Jensen DH; Glovinski PV; Jensen SB; Bardow A; Oliveri RS; Specht L; Thomsen C; Darkner S; Kiss K; Fischer-Nielsen A; von Buchwald C
Trials; 2017 Mar; 18(1):108. PubMed ID: 28270226
[TBL] [Abstract][Full Text] [Related]
19. Safety and Efficacy of Mesenchymal Stem Cells for Radiation-Induced Xerostomia: A Randomized, Placebo-Controlled Phase 1/2 Trial (MESRIX).
Grønhøj C; Jensen DH; Vester-Glowinski P; Jensen SB; Bardow A; Oliveri RS; Fog LM; Specht L; Thomsen C; Darkner S; Jensen M; Müller V; Kiss K; Agander T; Andersen E; Fischer-Nielsen A; von Buchwald C
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):581-592. PubMed ID: 29678523
[TBL] [Abstract][Full Text] [Related]
20. Xerostomia in head and neck malignancy.
Porter SR; Fedele S; Habbab KM
Oral Oncol; 2010 Jun; 46(6):460-3. PubMed ID: 20403723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
